Biotech Stocks

Sesen (SESN) Stock Just Lost a Bull

Sesen (SESN) stock tumbled nearly 40% following lousy preliminary results for the company’s Phase 3 study of Vicinium for the treatment of Non-Muscle …

Celgene Corporation (CELG) Stock Looks Like a Winner

Celgene (CELG) stock jumped over 30% in the past few trading days — and with good reason. Investors are excited over what is …

GW Pharmaceuticals (GWPH) Stock Finds a Fan in J.P Morgan

J.P Morgan analyst Cory Kasimov initiates coverage for medical cannabis company GW Pharmaceuticals (GWPH), calling it a “clear leader” in the field of cannabinoid …

Is Bausch Health (BHC) Stock Under Stress For Good Reason?

Bausch Health Companies (BHC) has been in the spotlight recently for participating in a stalking horse bid to scoop up Synergy Pharmaceuticals (SGYP) …

Tilray (TLRY) Stock Gets a Vote of Confidence from a Top Analyst

Tilray (TLRY) is making waves after announcing two partnerships with AB InBev (ABI) and Sandoz. The idea is that the larger companies should …

Hold Your Horses with Teva Pharmaceutical (TEVA) Stock

Teva (TEVA) stock’s chart for the past few months looks like nothing short of a roller-coaster ride. Shares of the Israeli drug giant …

Top Analyst Says Sarepta (SRPT) Stock Has More Room to Run

Christmas is over and it seems like people spent their gift money on stocks… Sarepta Therapeutics (SRPT) stock rose over 10% is the …

Amarin (AMRN) Stock Will Rise Again When the Dust Settles, Says Analyst

In early November, fish oil drug maker Amarin (AMRN) presented data called REDUCE-IT at the American Heart Association scientific sessions for a medication …

Bausch Health (BHC) Stock Set to See Big Gains, Says Analyst

Analysts and investors have all expressed their thoughts on how things will pan out for Bausch Health (BHC) when taking on Synergy’s (SGYP) …

Tilray (TLRY) Partnerships Could Be Setting the Company Up for Success, But the Stock Might Suffer

Tilray (TLRY) might be the little pot company that could. You could say the Beatles got it right — all you need is …